Oncolytics Biotech Inc. (ONC.TO) TSX

1.42

+0.03(+2.16%)

Updated at August 22 04:00PM

Currency In CAD

Valuation

Market Cap101.72M
Enterprise Value86.84M
P/E Ratio-5.76
PEG Ratio-1.12
Price/Sales Ratio0
Price/Book Ratio28.77
Enterprise/Revenue0
Enterprise/EBITDA-5.84

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterJune 30, 2025

Profitability

Profit Margin0
Operating Margin0

Management Effectiveness

Return On Assets-1.52
Return On Equity-4.4

Income Statement

Revenue0
Revenue/Share0
Gross Profit-424,000
EBITDA-34.88M
Net Income-31.71M
Diluted EPS-0.41

Balance Sheet

Total Cash14.63M
Total Cash/Share0.16
Total Debt888,000
Total Debt/Equity0.15
Current Ratio2.88
Book Value Per Share0.07

Price History

52-Week Change15.45
52-Week High2.08
52-Week Low0.45
Moving Average 50 Days1.31
Moving Average 200 Days1.08

Statistics

Average Volume285,775
Shares Outstanding100.18M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split Factor21:200
Last Split DateMay 25, 2018